Executive Development Programme in Vaccine Safety Monitoring

• Introduction to Vaccine Safety Monitoring: Understanding the importance of vaccine safety, the history of vaccine safety monitoring, and the current systems in place.
• Vaccine Pharmacovigilance: Introduction to vaccine pharmacovigilance, its importance, and the key principles and practices involved in monitoring vaccine safety.
• Adverse Event Following Immunization (AEFI): Understanding the definition, classification, and reporting of adverse events following immunization, as well as their impact on vaccine safety monitoring.
• Vaccine Safety Data Management: Best practices for collecting, analyzing, and interpreting vaccine safety data, as well as the use of data management systems and tools.
• Risk Assessment and Communication: Techniques for assessing and communicating vaccine safety risks, including understanding and addressing public concerns and ensuring transparency.
• Regulatory Frameworks for Vaccine Safety: Overview of the regulatory frameworks and guidelines for vaccine safety monitoring, including international standards and best practices.
• Vaccine Safety in Special Populations: Considerations for vaccine safety monitoring in special populations, including pregnant women, children, and the elderly.
• Ethical and Legal Considerations: Understanding the ethical and legal considerations in vaccine safety monitoring, including informed consent, data privacy, and liability.
• Emergency Preparedness and Response: Strategies for emergency preparedness and response in vaccine safety monitoring, including planning, coordination, and communication during public health emergencies.